InsidersTradesSigma
Apyx Medical Corp: directors' dealings · United States · SEC (Form 4)
SEC:apyx-medical-corp-d67db3US·SEC (Form 4)Mcap 166M€Healthcare
Explore the full directors' dealings record of Apyx Medical Corp, a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Apyx Medical Corp has published 3 public disclosures. Market capitalisation: €166m. The latest transaction was disclosed on 23 May 2022 (Levée d'options). Among the most active insiders: Waldman Lawrence. The full history is openly available.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
3.96 €
Analyst consensus
4 analystsStrong buy
6.00 €Target 6.50 €(+64%)8.00 €
Income statement
Revenue52.8 M€
Gross profit33.0 M€63% margin
Net income−11.2 M€-16.4% margin
Valuation
PER (forward)-15.1x
P/Book13.0x
Balance sheet & cash
Market cap166.0 M€
Total debt39.3 M€
Free Cash Flow−9.1 M€
Debt / Equity302%
Profitability & ownership
ROE-76.5%
ROA-4.4%
% insiders13.3%
% institutions49.6%
Last declaration on 23 May 2022
Declarations0 total
No declarations found
0 of 0 declarations